Cervical cancer is a disease that is caused by persistent human papillomavirus (HPV) infection. The fate of this sexually transmitted infection is determined by long-term host-viral and host-environmental interactions. Given that the majority population of Han Chinese have a similarity in genetic makeup, and cultural and social systems, it is not surprising to see a common spectrum of type-or variant-specific HPV prevalence and risk for cervical cancer in Taiwan, Hong Kong and Singapore. These populations also share similar behavioral and environmental exposure risks, as well as genetic susceptibility to cervical cancer. In this post-genomic era, when the code, control and function of the human genome are being quickly unveiled, new genetic and epigenetic biomarkers for cervical cancer are emerging systemically and in an overwhelming way. This review covers the conventional epidemiological risks of HPV infection and the development of cervical cancer, as well as the emerging new molecular biomarkers, in a focused population of Chinese subjects in Southeast Asia and Southern China. 
Ancestors and origin of Chinese populations in Taiwan and Southeast Asia
The Han people, sharing the same culture and language, are by far the largest ethnic group in the world.
Aside from the more than one billion people living in mainland China, over 30 million Han Chinese live in Taiwan, Hong Kong and Singapore, representing 98%, 95% and 77% of their populations, respectively. Most of them are immigrants from the southeast coast of China. Starting from the 5 th century, after the fall of the Han Dynasty, there were three waves of large-scale migration of people from Northern China to Southern China, and to the southeast coast, including Hong Kong (Fig. 1) . The massive movements resulted in the demographic expansion of Han people and their culture. Over one millennium, gene flow between the Han population and the native populations, most of them originating from Southeast Asia [1] , shaped the genetic profile of the population in Hong Kong, and those who had immigrated to Taiwan, Singapore and other countries in Southeast Asia over the past 400 years.
Observations of haplotypes in mitochondria DNA and Y chromosomes are in line with these historical accounts [2] . Although sharing common ancestry, populations in Taiwan, Hong Kong and Singapore differ to some extent from that in China, mainly because of gene flow from the native populations, such as the aborigines in Taiwan, and Thais, Malays and Indians in Singapore.
A recent large-scale immigration of Han Chinese from all over mainland China to Taiwan around 1949 also contributed significantly to the population constituents in Taiwan. Moreover, early colonization by the English, Spanish and Dutch from the 17 th to 19 th centuries, and the fast globalization of these three areas has also added characteristics to these Chinese immigrants.
The cultural and genetic makeup of Chinese immigrants in Taiwan, Hong Kong and Singapore very much determine the risk of cervical cancer development, by affecting behavior and environmental exposure relating to carcinogenesis, as well as genetic susceptibility to carcinogenesis. Known determinants of cervical carcinogenesis, including infection and persistence of human papillomavirus (HPV), sexual behavior, pregnancy and type of birth, exposure to smoking and infectious agents, and genetic and epigenetic changes of genes in Chinese immigrants, will be the focus of this review.
HPV coevolves with its human host
Infection by HPV, the first necessary etiological factor found in human cancers, has been found to cause a high risk of cervical cancer development. HPV coevolved with its human host long before the origin of Homo sapiens some 500 million years ago. In association with the migration of early human ancestors, the variants defined by small-scale DNA sequence variations of the locus control region (LCR) of specific HPV are unique to each ethnic group. For instance, specific haplotypes of HPV 16 and 18 were identified in the Chinese population living in Singapore [3] [4] [5] . Sequence analysis of HPV 31 and 52 also showed colocalization of HPV variants, collected from Taiwan and Hong Kong, in the evolutional tree [6] . A common pattern of HPV type and variant distribution, and genetic traits related to HPV infection and carcinogenesis are, therefore, expected in these three regions. Within this Chinese immigrant pattern of HPV distribution is the more prevalent HPV 52 and HPV 58 infections [7] , and the sharing of Asian variants of HPV 16 and 18 [3, 4] , which have different biological and clinical significance in cervical carcinogenesis. A showcase of the ethnic-specific distribution of HPV in Chinese populations is shown in Fig. 2 : the distribution of HPV genotypes in the general population in Taiwan differs greatly from that in Shenyang (a major city in Northern China) and less so from that in Shenzang (a major city in Southern China). Of note is the difference in the prevalence of HPV 16, which is very dominant in north China [8, 9] , less dominant in south China [10] , and is similar to HPV 52 and 58 in Taiwan [11] . A similar ethnic-specific distribution of HPV types was also noted in cervical cancer from different areas. As shown in Fig. 3 [12] [13] [14] [15] , HPV 16 was found in 80% of cervical cancers in China [12] but was found in only 50% of cervical cancers in Taiwan and south China [13] , and other Asian countries [14, 16] . In areas with Chinese immigrants, such as Taiwan [17, 18] and Hong Kong [19] , and in Southern China [20, 21] , HPV 58 is the second or the third most common HPV type found in cervical cancer but the same HPV is relatively rare [7, 18, [28] [29] [30] [31] shows the oncogenic risk of HPV infections in different grades of cervical neoplasia in Chinese subjects living in Taiwan and Hong Kong. Depending on the nature and stringency of selection of cases and controls, the odds ratio of finding squamous intraepithelial lesions of high-grade (HSIL) or above is 29-1280 times higher in high-risk HPV (HR-HPV)-infected women than non-infected women [7, 28] . HPV type-specific risk for HSIL or above lesions was higher in women infected with HPV 16 than those infected with HPV 58 and HPV 52 [29] . An earlier study in Taiwan also showed that HPV 52 and 58 had a much smaller risk for HSIL than HPV 16 [18] . Not only is it less risky but HPV 58-related cervical cancers also had a favorable survival compared to those with HPV 16 and HPV 18 [17] . In comparison to HPV 16, 18, 31 and 33, the E6 and E7 genes of HPV 52 had a much more limited in vitro transformation capability [32] . It rarely integrates into host genome in cervical cancer [33] . In analysis of the distributional proportion of different HPV types in the spectrum of cervical neoplasia, HPV 52 was found to be highly prevalent in precancerous infections but much less in invasive cer vical cancer [34] , indicating a less oncogenic nature than other high risk types of HPV.
In addition to HPV genotypes, a study in Hong Kong showed that DNA sequence variations at the E7 gene of HPV 58 conferred different risks for cervical cancer. For instance, the E7 632C > T (T20I) and E7 760G > A (G63S) variants were associated with the severity of cervical neoplasia. HPV 58 variants carrying these two substitutions had a 6.9-fold higher risk for cervical cancer than variants without these substitutions [35] .
With regard to HPV infection load, the amount of HR-HPV infection as measured by Hybrid Capture 2 (Digene, Silver Spring, MD, USA), a higher viral load conferred higher risk for HSIL or above lesions [30, 31] . Looking in more detail, the significance of HPV infection load in different severities of cervical neoplasia is HPV type-dependent. Two studies in Taiwan [33, 36] showed that the viral load of HPV 16, HPV 18 and HPV 52 correlated significantly with disease severity. How ever, infection loads of HPV 58, HPV 31 and HPV 33 do not correlate to clinical severity. The wide variation in HPV infection loads among different HPV types and among different severities of squamous intraepithelial lesions makes the viral load test unrealistic for differentiating different severities of cervical neoplasia. risk factors in these studies. The female smoking population in Chinese societies is typically low [38] . A recent nationwide survey of 4,160,844 Taiwanese adults revealed a female smoking rate of 4.5% compared to 42.8% in males.
Other environmental and behavioral risk factors for cervical carcinogenesis in Chinese immigrants

Genetic predispositions for cervical carcinogenesis
Large-scale epidemiological evidence of a genetic pre disposition for cervical cancer has been documented [45] . DNA polymorphisms of different cancerrelated genes may confer different risks for cervical cancer. [52] , HLA-DRB1*12, which is protective for CIN and cervical cancer, and HLA-DRB1*03, which is a risk for HPV 18 CIN and cervical cancer [53] . Interestingly, HLA-DQB1*03, previously found to be a risk allele for cervical cancer in European women, was found to be protective in the Hong Kong study [52] .
New biomarkers in development: chromosomal loss, methylationsilenced genes and protein markers
In additional to environmental and constitutional factors, genetic alterations affecting the growth, apoptosis, differentiation and genome stability of cells, and the angiogenesis and remodeling of tissue, are usually crucial steps in cancer development. They, therefore, serve as significant diagnostic and prognostic markers for cancer. They include loss of heterozygosity (LOH) or allelic loss, gene mutations and methylation-induced gene silencing.
With the dominant oncogenic effect of HPV, which con trols cell cycle by its oncoproteins, mutations of tumor suppressor genes commonly found in other cancers were lacking in cervical cancer. Studies in Taiwan, Hong Kong and Singapore on P53 [54] [55] [56] , FHIT [57] , RII [58] , TSG101 [59] , CYCD1, CDK4 [60] and PTEN [61] showed absence of loss of function mutations. However, larger-scale chromosomal alterations, such as LOH and methylation-mediated gene silencing, were frequently found in different grades of cervical carcinogenesis. Table 4 [57,62-77] summarizes these genetic and epigenetic changes in cervical cancers in the three areas. Allelic losses at 3p14, 3p22-24 and 3p25 were repeatedly noted in studies in Taiwan [57, 58, 62, 63] and Hong Kong [64] [65] [66] . Allelic losses at other chromosomal loci, such as 5p15-5p13 [62] , 1p31, 1p36.3 and 1q25 [67, 68] , were also noted in studies in Taiwan and Hong Kong. While the crucial genes responsible for cancer development have yet to be identified in these chromosomal loci, detection of LOH and other microsatellite alterations in exfoliate cervical epithelial cells may help in the early diagnosis of cervical cancer [63] . DNA hypermethylation, with subsequent epigenetic silencing of tumor suppressor genes, is one of the hallmarks of cancer and accounts for the second hit of the two hit hypothesis of carcinogenesis [78, 79] . The epigenetic silencing of tumor suppressor genes is commonly seen in cervical cancer worldwide [80, 81] , as well as in Hong Kong, Taiwan and Singapore (Table 4) . Among the methylated genes were P16 at 9p21 [69] , BLU and RASSF1A at 3p21.3 [70, 71] , PTEN at 10q23 [72] , P73 at 1p36 [73] , DAPK at 9q34, MGMT at 10q26 [74] and DLC1 at 8p22 [75] . As noted, some of these methylation markers showed dramatic differences among normal, precancerous and invasive carcinoma of the uterine cervix, and can be detected in cervical scraping samples, which potentially allows self-sampling, and feature a promising diagnostic biomarker compatible with and even more specific than the HPV test.
A number of protein biomarkers, typically defined by specific antibodies, have been investigated in cervical cancer. Among them is p16/INK4A (p16), which shows promising sensitivity and specificity in the diagnosis of cervical high-grade dysplasia and invasive cancer. p16 is a tumor suppressor protein, also known as a cyclin-dependent kinase (CDK) inhibitor, which decelerates the cell cycle by inactivating CDKs. p16 pro tein was found to be overexpressed in cervical preneoplastic and neoplastic lesions in which HR-HPV existed [82, 83] . Several studies in Taiwan [84] [85] [86] and elsewhere have demonstrated that p16 immunocytochemistry can be applied successfully to conventional Pap smears and tissue sections, and helps to clarify am biguous cytological and pathological interpretations such as atypical squamous cells of unknown significance (ASCUS), atypical glands of unknown significance (AGUS) and squamous intraepithelial lesions [84] [85] [86] . Aside from p16, other protein markers, including cell proliferation markers such as hTERT and Ki-67, were also found to be associated with HSIL and invasive cervical cancer [87] [88] [89] [90] . However, these markers also appeared in pro liferative and reactive cells, and thus limited their specificity and future applications. Genomic deletion on 3p and 5p correlated with genetic or epigenetic p53 62 inactivation pathways, including p53 mutation, genetic deletion of p53 and cervical infection with HPV.
Hong Kong 3p14, 3p25, 9 loci LOH was found in 10/12 ICC at 3p25 and 10/11 cases at 3p14.
64-66 at 3p
The incidence of LOH at 3p13 was the highest among 9 markers examined. Frequent LOH was found at 3p26 (41%), 3p25 (31%), 3p25.1 (24%), 3p21 (29%), 3p1 (24%), and 3p13 (25%) in CIN. 
Perspectives
In this post-genomic era when the code, control and function of the human genome is being quickly unveiled, characteristic genotypic and phenotypic changes in human cancers are being discovered at an ever increasing pace. With the aid of various genome-wide technologies, genetic and epigenetic markers for cancers are emerging systemically and in an overwhelming way. With the massive candidate markers being discovered, each has to be verified and tested clinically in line with the risk, diagnosis and prognosis of cancer. In a disease that is caused by persistent viral infection, and whose fate is determined by long-term host-viral and host-environmental interactions, it is not surprising to see a common spectrum of type-or variant-specific HPV prevalence, with similar behavioral and environmental risk factors for cervical cancer in people in Taiwan, Hong Kong and Singapore, who share a great similarity in genetic background, culture and social systems. With the emergence of more and more candidate tumor markers, and the rate-limiting nature of translational research, further investigation into this fascinating disease will demand systematic work among these and other regions in a collaborative, as well as competitive, way.
